Sulphasalazine Increases Fibrinolysis in the Anaesthetised Rat

• References

• 1 Goldman PA, Peppercorn MA. Sulfasalazine. N Engl J Med 1975; 293: 20-23
• 2 Bach MK, Brashler JR, Johnson MA. Inhibition by sulphasalazine of LTC synthetase and of rat liver glutathione S-transferases. Biochem Pharmacol 1985; 34: 2695-2704
• 3 Molin L, Stendahl O. The effect of sulphasalazine and its active components on human polymorphonuclear leucocyte function in relation to ulcerative colitis. Acta Med Scand 1979; 206: 451-454
• 4 Broughton-Smith NK, Hawkey CJ, Rosam AC, Whittle BJ R. Sulphasalazine inhibits platelet aggregation and thromboxane formation in human platelets and kidney. Br J Pharmacol 1986; 88: 391 P
• 5 Farr M, Tunn E, Bacon PE, Smith DH. Hypogammaglobulinaemia and thrombocytopaenia associated with sulphasalazine therapy in rheumatoid arthritis. Ann Rheum Dis 1985; 44: 723-724
• 6 Mechanick JI. Coomb’s positive hemolytic anaemia following sulphasalazine therapy in ulcerative colitis: case reports, reviews, and discussion of pathogenesis. Mt Sinai J Med NY 1985; 52: 667-670
• 7 Nilsson IM, Olow B. Fibrinolysis induced by streptokinase in man. Acta Chir Scand 1962; 123: 247-266
• 8 Hussaini I, Moore PK. Fibrinolytic effect of prostanoids in the rat. Br J Pharmacol 1985; 86: 813 P
• 9 Tranquille N, Erneis JJ. Release of tissue type plasminogen activator is induced in rats by leukotrience C₄ and D₄, but not prostaglandins E₁, E₂ and I₂ . Br J Pharmacol 1988; 93: 156-164
• 10 Hoult JRS, Moore PK, Ramcharan E. Sulphasalazine inhibits the pulmonary inactivation of prostaglandins in the rat in vivo. Br J Pharmacol 1979; 66: 101 P